Active Filters
- 2022Clear filter
![SWOG Front Line banner](/sites/default/files/styles/news_recent/public/news/2022-05/FrontLineHeader.web-sized_1.png?itok=AGOuzzYn)
May 20, 2022
Marking Clinical Trials Day 2022 by making our trials more representative
![SWOG Front Line banner](/sites/default/files/styles/news_recent/public/news/2022-05/FrontLineHeader.web-sized.png?itok=egtv6kK8)
May 6, 2022
![SWOG Front Line banner](/sites/default/files/styles/news_recent/public/news/2022-04/FrontLineHeader.web-sized_2.png?itok=koJGcuHL)
Apr 29, 2022
![SWOG Front Line banner](/sites/default/files/styles/news_recent/public/news/2022-04/FrontLineHeader.web-sized_1.png?itok=_FOoS9rQ)
Apr 22, 2022
The iMATCH pilot: immunotherapy comes of age with a master protocol
![SWOG Front Line banner](/sites/default/files/styles/news_recent/public/news/2022-04/FrontLineHeader.web-sized_0.png?itok=Gfw4-Tr6)
Apr 15, 2022
![S1616 results at AACR 2022](/sites/default/files/styles/news_recent/public/news/2022-04/press-release-web-graphic-S1616_0.png?itok=uxB1tHGG)
Apr 8, 2022
Reversing resistance to PD-1 inhibitors with combination immunotherapy in patients with advanced melanoma
![SWOG Front Line banner](/sites/default/files/styles/news_recent/public/news/2022-04/FrontLineHeader.web-sized.png?itok=i5rBPsDV)